2021
DOI: 10.3390/pharmaceutics13030389
|View full text |Cite
|
Sign up to set email alerts
|

Co-Amorphous Drug Formulations in Numbers: Recent Advances in Co-Amorphous Drug Formulations with Focus on Co-Formability, Molar Ratio, Preparation Methods, Physical Stability, In Vitro and In Vivo Performance, and New Formulation Strategies

Abstract: Co-amorphous drug delivery systems (CAMS) are characterized by the combination of two or more (initially crystalline) low molecular weight components that form a homogeneous single-phase amorphous system. Over the past decades, CAMS have been widely investigated as a promising approach to address the challenge of low water solubility of many active pharmaceutical ingredients. Most of the studies on CAMS were performed on a case-by-case basis, and only a few systematic studies are available. A quantitative anal… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
59
1
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 85 publications
(62 citation statements)
references
References 153 publications
(248 reference statements)
1
59
1
1
Order By: Relevance
“…The development of co-amorphous systems is an emerging amorphization strategy to improve the physicochemical and biopharmaceutical properties of the drug. The co-amorphous systems involve combining drug and low molecular weight organic excipient (the co-former) in an equimolar ratio using suitable methods to yield a homogenous amorphous single phase [27][28][29]. It should be noted that several studies have established the ability of citric acid and tartaric acid to form co-amorphous systems with weakly basic drugs [30][31][32][33], which corroborates our results on the formation of BX795-tartaric acid/citric acid co-amorphous systems.…”
Section: Discussionsupporting
confidence: 89%
“…The development of co-amorphous systems is an emerging amorphization strategy to improve the physicochemical and biopharmaceutical properties of the drug. The co-amorphous systems involve combining drug and low molecular weight organic excipient (the co-former) in an equimolar ratio using suitable methods to yield a homogenous amorphous single phase [27][28][29]. It should be noted that several studies have established the ability of citric acid and tartaric acid to form co-amorphous systems with weakly basic drugs [30][31][32][33], which corroborates our results on the formation of BX795-tartaric acid/citric acid co-amorphous systems.…”
Section: Discussionsupporting
confidence: 89%
“…Due to the long path and high cost of discovering and developing new therapeutic molecules, the trend is observed to improve the physicochemical properties of API with a known profile of action [ 10 , 11 ]. In drugs belonging to the 2 BCS group, the research aims to improve solubility, thus increasing bioavailability.…”
Section: Introductionmentioning
confidence: 99%
“…In recent years, a great interest was given to the research on the design of new polymeric materials with adapted properties and multiple functionalities, from technology to biomedical and environmental applications [1][2][3]. In this context, the physical mixing of two polymers or more represents simplest conceptual way to achieve the desired properties of new materials.…”
Section: Introductionmentioning
confidence: 99%
“…Nowadays, cellulose derivatives gained substantial consideration, due to their specific properties, e.g., biodegradability, biocompatibility, nontoxicity, solubility in water, etc., having large applicability in the chemical industries, biomedical, pharmaceutical, cosmetics, water desalination [1,2,21,22], as an effect of special viscometric behavior in solution. Particular properties of these derivatives can be optimized by utilization of polymer blends principle, which permits attaining of new models of materials, with a wide range of qualities [23].…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation